| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.71B | 7.56B | 7.95B | 7.87B | 8.99B | 7.00B |
| Gross Profit | 2.65B | 2.70B | 2.68B | 2.10B | 1.29B | 142.67M |
| EBITDA | 1.40B | 1.40B | 1.15B | 787.37M | -356.13M | -1.34B |
| Net Income | 2.64B | 2.68B | 1.56B | 734.18M | -221.49M | -2.06B |
Balance Sheet | ||||||
| Total Assets | 15.29B | 16.47B | 13.58B | 11.61B | 10.89B | 9.39B |
| Cash, Cash Equivalents and Short-Term Investments | 11.03B | 12.18B | 10.22B | 9.51B | 9.11B | 6.62B |
| Total Debt | 5.91M | 10.43M | 6.47M | 6.36M | 8.40M | 10.51M |
| Total Liabilities | 3.17B | 3.59B | 3.40B | 3.17B | 3.07B | 2.01B |
| Stockholders Equity | 12.12B | 12.87B | 10.18B | 8.44B | 7.82B | 7.38B |
Cash Flow | ||||||
| Free Cash Flow | 1.19B | 1.61B | 1.77B | 183.51M | 1.82B | -947.91M |
| Operating Cash Flow | 1.19B | 1.62B | 1.77B | 189.05M | 1.84B | -908.41M |
| Investing Cash Flow | 23.13M | -2.35B | -1.94B | 1.23B | 158.59M | -3.86B |
| Financing Cash Flow | -4.23M | 82.51M | -62.06M | -307.68M | -2.91M | 2.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$14.10B | 14.00 | 41.82% | ― | 35.42% | 87.47% | |
70 Outperform | HK$25.10B | ― | 23.66% | ― | -2.36% | 73.71% | |
64 Neutral | HK$4.30B | 10.86 | -8.12% | ― | 3.16% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | HK$8.28B | 49.57 | 6.99% | ― | 19.62% | 31.05% | |
54 Neutral | HK$38.93B | -35.61 | -13.37% | ― | 22.96% | 56.71% | |
42 Neutral | HK$6.06B | -27.95 | -66.11% | ― | 18.94% | 89.36% |